{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:24:21Z","timestamp":1767666261486,"version":"3.41.2"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":101,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The degree to which sarcoidosis patients are affected by autoimmune diseases is poorly understood. Prior studies of autoimmune co-morbidities in sarcoidosis have focused on populations outside the USA or have been impeded by small sample sizes and limited scope. This case\u2013control study evaluated the association between sarcoidosis and autoimmune diseases in a large, diverse cohort based in the USA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data from the All of Us research programme to conduct a case\u2013control study involving patients \u226518\u2009years old, from 2018 to the present, diagnosed with sarcoidosis. Sarcoidosis cases and age-, sex- and race-matched controls were identified in a 1:4 ratio. Autoimmune co-morbidities were compared between sarcoidosis patients and controls in univariable and multivariable analyses using logistic regression. The degree of association was measured using the odds ratio (OR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1408 sarcoidosis cases and 5632 controls were included in this study. Seven of 24 examined autoimmune diseases were significantly associated with sarcoidosis in our multivariable analysis (P\u2009&amp;lt;\u20090.05). The composite variable of any autoimmune disease was also significantly associated with sarcoidosis (OR = 2.29, P\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We demonstrate an association between sarcoidosis and multiple autoimmune diseases in a large and diverse cohort based in the USA. These results underscore the need for careful screening of sarcoidosis patients for concomitant autoimmune disease.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rap\/rkad030","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T13:24:36Z","timestamp":1681305876000},"source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune comorbidities associated with sarcoidosis: a case-control study in the All of Us research program"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-7250","authenticated-orcid":false,"given":"Michael J","family":"Murphy","sequence":"first","affiliation":[{"name":"Yale School of Medicine, Yale University , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Princess","family":"Edemobi","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Yale University , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey C","family":"Leasure","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridu","family":"Gulati","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Yale University , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J","family":"Miller","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Damsky","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University , New Haven, CT, USA"},{"name":"Department of Pathology, Yale School of Medicine , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University , New Haven, CT, USA"},{"name":"Section of Biomedical Informatics and Data Science, Yale School of Medicine , New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat Commun"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/thorax.58.6.519","article-title":"Increased interleukin-13 expression in patients with sarcoidosis","volume":"58","author":"Hauber","year":"2003","journal-title":"Thorax"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/ajrccm.162.3.9901099","article-title":"Familial sarcoidosis is linked to the major histocompatibility complex region","volume":"162","author":"Sch\u00fcrmann","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s10038-007-0185-7","article-title":"Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis","volume":"52","author":"Medica","year":"2007","journal-title":"J Hum Genet"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jaad.2018.07.051","article-title":"Immune checkpoint inhibitors and the development of granulomatous reactions","volume":"81","author":"Cornejo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1164\/ajrccm.156.5.97-01037","article-title":"TCR V \u03b2 families in T cell clones from sarcoid lung parenchyma, BAL, and blood","volume":"156","author":"Zissel","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCP.0000000000000809","article-title":"Sarcoidosis and autoimmunity","volume":"27","author":"Song","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"105236","DOI":"10.1016\/j.jbspin.2021.105236","article-title":"Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients","volume":"88","author":"Brito-Zer\u00f3n","year":"2021","journal-title":"Joint Bone Spine"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1346-8138.13654","article-title":"Comorbid autoimmune diseases in patients with sarcoidosis: a nationwide case\u2013control study in Taiwan","volume":"44","author":"Wu","year":"2017","journal-title":"J Dermatol"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/pgmj.2008.067769","article-title":"Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database","volume":"85","author":"Rajoriya","year":"2009","journal-title":"Postgrad Med J"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1340331","article-title":"High frequency of endocrine autoimmunity in patients with sarcoidosis","volume":"134","author":"Papadopoulos","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamadermatol.2013.4256","article-title":"Sarcoidosis and psoriasis: a case series and review of the literature exploring co-incidence vs coincidence","volume":"149","author":"Wanat","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BSR20120055","article-title":"Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases","volume":"32","author":"Correa","year":"2012","journal-title":"Biosci Rep"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"e0122639","DOI":"10.1371\/journal.pone.0122639","article-title":"BTNL2 gene polymorphism and sarcoidosis susceptibility: a meta-analysis","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/hmg\/ddi436","article-title":"Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15","volume":"15","author":"Traherne","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"e53613","DOI":"10.1371\/journal.pone.0053613","article-title":"Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"2023041720250126800_","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00296-011-1924-9","article-title":"Association of TNF-\u03b1 promoter-308 A\/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis","volume":"32","author":"Pan","year":"2012","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkad030\/49864617\/rkad030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/7\/2\/rkad030\/50001306\/rkad030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/7\/2\/rkad030\/50001306\/rkad030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T15:49:48Z","timestamp":1702223388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkad030\/7115846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4,12]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkad030","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2023,1,1]]},"article-number":"rkad030"}}